Surgical Innovations Group plc
Additional Listing
12 July 2004
Surgical Innovations Group plc (the 'Company') has made the following
application for new ordinary shares of 1p each ('new ordinary shares') to be
admitted to trading on AIM:
- 77,142 new ordinary shares have been issued for cash at a price of 1.75p
per share to Mr G Bowland in respect of his entitlement under the
Company's Sharesave Scheme.
Following the allotment of these new ordinary shares, Mr Bowland's total
holding in the Company will be 77,142 ordinary shares.
Dealings are expected to commence on 19 July 2004.
Enquiries:
Graham Bowland, Finance Director Tel: +44(0) 113 2307597
Surgical Innovations Group plc
Philip Johnson, Director Tel: +44 (0) 161 838 9140
Westhouse Securities LLP
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.